Interleukin-10 protects the ischemic heart from reperfusion injury via the STAT3 pathway

Surgery

Volumn 150, Issue 2, 2011, Pages 231-239

  Manukyan, Mariuxi C ^a   Alvernaz, Collin H ^a   Poynter, Jeffrey A ^a   Wang, Yue ^a   Brewster, Benjamin D ^a   Weil, Brent R ^a   Abarbanell, Aaron M ^a   Herrmann, Jeremy L ^a   Crowe, Brandon J ^a   Keck, Andrew C ^a   Meldrum, Daniel R ^a,b  

^a INDIANA UNIVERSITY   (United States)

^b METHODIST HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; PROTEIN INHIBITOR; STAT3 PROTEIN; STATTIC; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; HEART FUNCTION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; TISSUE SECTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; DISEASE MODELS, ANIMAL; INTERLEUKIN-10; MALE; MYOCARDIAL REPERFUSION INJURY; PERFUSION; RATS; RATS, SPRAGUE-DAWLEY; STAT3 TRANSCRIPTION FACTOR;

EID: 79960916464     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2011.05.017     Document Type: Article

References (25)

1. S. Wan, J.L. LeClerc, and J.L. Vincent Cytokine responses to cardiopulmonary bypass: lessons learned from cardiac transplantation Ann Thorac Surg 63 1997 269 276 (Pubitemid 27039089)
2. A. Anselmi, A. Abbate, F. Girola, G. Nasso, G.G. Biondi-Zoccai, and G. Possati Myocardial ischemia, stunning, inflammation, and apoptosis during cardiac surgery: a review of evidence Eur J Cardiothorac Surg 25 2004 304 311 (Pubitemid 38340562)
3. H.A. Hennein, H. Ebba, J.L. Rodriguez, S.H. Merrick, F.M. Keith, and M.H. Bronstein Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization J Thorac Cardiovasc Surg 108 1994 626 635 (Pubitemid 24330237)
4. D.L. Ngaage Off-pump coronary artery bypass grafting: the myth, the logic and the science Eur J Cardiothorac Surg 24 2003 557 570 (Pubitemid 37162522)
5. P. Giomarelli, S. Scolletta, E. Borrelli, and B. Biagioli Myocardial and lung injury after cardiopulmonary bypass: role of interleukin (IL)-10 Ann Thorac Surg 76 2003 117 123 (Pubitemid 36819726)
6. E. Duggan, E. Caraher, K. Gately, M. O'Dwyer, E. McGovern, and D. Kelleher Tumor necrosis factor-alpha and interleukin-10 gene expression in peripheral blood mononuclear cells after cardiac surgery Crit Care Med 34 2006 2134 2139 (Pubitemid 44305616)
7. P.J. Murray Understanding and exploiting the endogenous interleukin-10/STAT3-mediated anti-inflammatory response Curr Opin Pharmacol 6 2006 379 386
8. S. Dhingra, A.K. Sharma, R.C. Arora, J. Slezak, and P.K. Singal IL-10 attenuates TNF-alpha-induced NF kappaB pathway activation and cardiomyocyte apoptosis Cardiovasc Res 82 2009 59 66
9. M.J. Thomassen, L.T. Divis, and C.J. Fisher Regulation of human alveolar macrophage inflammatory cytokine production by interleukin-10 Clin Immunol Immunopathol 80 1996 321 324
10. H.J. Kim, J. Hart, N. Knatz, M.W. Hall, and M.D. Wewers Janus kinase 3 down-regulates lipopolysaccharide-induced IL-1 beta-converting enzyme activation by autocrine IL-10 J Immunol 172 2004 4948 4955 (Pubitemid 38456420)
11. P. Krishnamurthy, J. Rajasingh, E. Lambers, G. Qin, D.W. Losordo, and R. Kishore IL-10 inhibits inflammation and attenuates left ventricular remodeling after myocardial infarction via activation of STAT3 and suppression of HuR Circ Res 104 2009 e9 e18
12. R. Hayward, T.O. Nossuli, R. Scalia, and A.M. Lefer Cardioprotective effect of interleukin-10 in murine myocardial ischemia-reperfusion Eur J Pharmacol 334 1997 157 163 (Pubitemid 27451984)
13. Z. Yang, B. Zingarelli, and C. Szabo Crucial role of endogenous interleukin-10 production in myocardial ischemia/reperfusion injury Circulation 101 2000 1019 1026 (Pubitemid 30131705)
14. M.A. Cassatella, S. Gasperini, C. Bovolenta, F. Calzetti, M. Vollebregt, and P. Scapini Interleukin-10 (IL-10) selectively enhances CIS3/SOCS3 mRNA expression in human neutrophils: evidence for an IL-10-induced pathway that is independent of STAT protein activation Blood 94 1999 2880 2889 (Pubitemid 29477317)
15. L.M. Williams, U. Sarma, K. Willets, T. Smallie, F. Brennan, and B.M. Foxwell Expression of constitutively active STAT3 can replicate the cytokine-suppressive activity of interleukin-10 in human primary macrophages J Biol Chem 282 2007 6965 6975 (Pubitemid 47093676)
16. L. Williams, L. Bradley, A. Smith, and B. Foxwell Signal transducer and activator of transcription 3 is the dominant mediator of the anti-inflammatory effects of IL-10 in human macrophages J Immunol 172 2004 567 576 (Pubitemid 38020514)
17. M. Wang, L. Baker, B.M. Tsai, K.K. Meldrum, and D.R. Meldrum Sex differences in the myocardial inflammatory response to ischemia-reperfusion injury Am J Physiol Endocrinol Metab 288 2005 E321 E326
18. M.D. Goodman, S.E. Koch, G.A. Fuller-Bicer, and K.L. Butler Regulating RISK: a role for JAK-STAT signaling in postconditioning? Am J Physiol Heart Circ Physiol 295 2008 H1649 H1656
19. J. Cha, Z. Wang, L. Ao, N. Zou, C.A. Dinarello, and A. Banerjee Cytokines link Toll-like receptor 4 signaling to cardiac dysfunction after global myocardial ischemia Ann Thorac Surg 85 2008 1678 1685 (Pubitemid 351608179)
20. D.R. Meldrum Tumor necrosis factor in the heart Am J Physiol 274 3 Pt 2 1998 R577 R595
21. B.S. Cain, D.R. Meldrum, C.A. Dinarello, X. Meng, K.S. Joo, and A. Banerjee Tumor necrosis factor-alpha and interleukin-1beta synergistically depress human myocardial function Crit Care Med 27 1999 1309 1318 (Pubitemid 29379369)
22. K. Asadullah, W. Sterry, and H.D. Volk Interleukin-10 therapy-review of a new approach Pharmacol Rev 55 2003 241 269
23. J. Schust, B. Sperl, A. Hollis, T.U. Mayer, and T. Berg Stattic: a small-molecule inhibitor of STAT3 activation and dimerization Chem Biol 13 2006 1235 1242 (Pubitemid 44750735)
24. Jolly SS, Niemela K, Xavier D, Widimsky P, Budaj A, Valentin V, et al. Design and rationale of the radial versus femoral access for coronary intervention (RIVAL) trial: a randomized comparison of radial versus femoral access for coronary angiography or intervention in patients with acute coronary syndromes. Am Heart J 161:254-60.e1-4.
25. A. Räisänen-Sokolowski, T. Glysing-Jensen, and M.E. Russell Leukocyte-suppressing influences of interleukin (IL)-10 in cardiac allografts: insights from IL-10 knockout mice Am J Pathol 153 1998 1491 1500 (Pubitemid 28509906)